Moinzadeh, P., Hunzelmann, N., & Krieg, T. (2013). Pharmacology and rationale for imatinib in the treatment of scleroderma. J Exp Pharmacol.
Čikaški stil citiranjaMoinzadeh, Pia, Nicolas Hunzelmann, i Thomas Krieg. "Pharmacology and Rationale for Imatinib in the Treatment of Scleroderma." J Exp Pharmacol 2013.
MLA način citiranjaMoinzadeh, Pia, Nicolas Hunzelmann, i Thomas Krieg. "Pharmacology and Rationale for Imatinib in the Treatment of Scleroderma." J Exp Pharmacol 2013.
Upozorenje: Ovi citati možda nisu uvijek 100% točni.